A single 0.5 mg dose of Ativan (lorazepam) produces noticeable effects for roughly six to eight hours, but the drug itself lingers in your body much longer than you feel it working. Lorazepam has an elimination half-life of about 14 to 16 hours, meaning it takes your body that long to clear just half of a dose. By the time the drug is functionally gone from your bloodstream, roughly three days have passed. Detection on a drug test, though, stretches even further, with urine tests capable of picking up traces for six days or more after a single dose.
What 0.5 mg Actually Does
Ativan is the brand name for lorazepam, a benzodiazepine prescribed for anxiety, insomnia, seizures, and procedural sedation. The 0.5 mg tablet is the lowest commonly available dose, and it sits at the bottom of the therapeutic range. In a controlled study comparing doses, researchers classified 0.5 mg as a “non-clinically effective” dose for treating experimentally induced anxiety, while 2 mg was classified as clinically effective. When participants were given 0.5 mg an hour before a carbon dioxide inhalation challenge designed to provoke anxiety, their fear and tension ratings did not differ from placebo in a statistically meaningful way. The 2 mg dose, by contrast, significantly reduced feelings of wanting to leave the room and showed clear dose-dependent reductions in fearfulness, stress, and worry.
1PubMed. The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO₂-induced anxietyThat does not mean 0.5 mg does nothing. Many people feel mild sedation, some muscle relaxation, and a slight anxiolytic effect at this dose, particularly if they are benzodiazepine-naive or have a smaller body size. But if you are wondering whether the drug is “working” at 0.5 mg and feel underwhelmed, the research suggests that is expected. The dose is often used as a starting point, allowing a prescriber to titrate upward if needed while minimizing side effects.
How Long the Effects Feel Active
Lorazepam is classified as an intermediate-acting benzodiazepine. After you take a tablet by mouth, blood levels typically peak about two to two and a half hours later. In a pharmacokinetic study comparing different routes of administration, oral lorazepam reached peak concentration at roughly 2.4 hours after the dose, with an absorption half-life of around 33 minutes.
2PubMed. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepamMost people notice the sedative and calming effects begin within 30 to 60 minutes and feel them most strongly around the two-hour mark. From there, the subjective effects taper gradually. For a low dose like 0.5 mg, most of the perceptible effect is gone within about six hours, though some residual drowsiness or cognitive slowing can linger a bit longer. The drug itself, however, continues to circulate long after you stop feeling it, which matters for drug interactions, driving safety, and detection.
The Elimination Half-Life
The elimination half-life tells you how long it takes for your body to reduce the drug’s concentration by half. For lorazepam, that number is roughly 14 to 16 hours in healthy adults. A study comparing lorazepam clearance in younger and older adults found an average half-life of 14.1 hours in the younger group and 15.9 hours in the elderly group, a difference that was not statistically significant.
3PubMed. Lorazepam kinetics in the elderlyA common pharmacological rule of thumb is that it takes about five half-lives to eliminate a drug almost completely from your system. With a 14-hour half-life, that translates to roughly 70 hours, or about three days. With a 16-hour half-life, you are closer to 80 hours. So for a single 0.5 mg dose, the lorazepam itself is essentially cleared from your blood within three to four days, though its metabolites may hang around a bit longer.
How Your Body Processes Lorazepam
This is where lorazepam differs from many other benzodiazepines in a way that matters clinically. Most benzodiazepines are broken down through a liver process called oxidation, which is heavily influenced by age, liver health, and interactions with other drugs. Lorazepam takes a different metabolic route. It is cleared primarily through a process called glucuronidation, where a sugar molecule is attached to the drug, making it water-soluble and easy to excrete in urine.
4PubMed. The glucuronidation of R- and S-lorazepam: human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugsThe resulting metabolite, lorazepam glucuronide, is inactive and nontoxic. In a study of lorazepam elimination, about 64% of the dose was recovered as this glucuronide metabolite in urine, and less than 0.4% appeared in feces.
5PubMed. Effect of renal impairment and hemodialysis on lorazepam kineticsThis glucuronidation pathway is one reason lorazepam is often preferred in certain clinical populations. Because it bypasses the oxidative liver enzymes that many other drugs compete for, lorazepam’s clearance is less affected by liver disease and aging than, say, diazepam or chlordiazepoxide. The elderly clearance study found that while total clearance was about 22% lower in older adults, the half-life itself did not change significantly.
3PubMed. Lorazepam kinetics in the elderlyDrug Test Detection Windows
If your concern is whether lorazepam will show up on a drug test, the detection window extends well beyond the point when you stop feeling the drug. A forensic study that tracked lorazepam after a single therapeutic dose found that urine tested positive for the drug for over 144 hours, which is six full days. The peak urine concentration appeared about 24 hours after the dose, and low levels in the range of 2 to 4 nanograms per milliliter were still detectable at the 144-hour mark.
6PubMed. Windows of detection of lorazepam in urine, oral fluid and hair, with a special focus on drug-facilitated crimesFor a 0.5 mg dose, the absolute amounts in urine would be smaller than for a standard therapeutic dose (typically 1 to 2 mg), so the detection window could be somewhat shorter. But the general ballpark of several days for urine detection remains a reasonable estimate even at the lower dose. Hair testing can detect benzodiazepines for much longer, potentially weeks to months, though this is more commonly used in forensic settings than in routine workplace screening.
Why Standard Urine Screens Often Miss Benzodiazepines
Here is something that surprises many people: standard immunoassay-based urine drug screens, the kind used in most workplace and clinical testing, are actually quite poor at detecting lorazepam. These rapid tests were originally designed to detect older benzodiazepines like diazepam and its metabolites. Lorazepam, because it is excreted primarily as a glucuronide conjugate rather than as the parent drug, cross-reacts poorly with these standard immunoassay panels, leading to a significant rate of false-negative results.
7Journal of Mass Spectrometry and Advances in the Clinical Lab. Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimensIn practical terms, this means a person taking lorazepam as prescribed could test negative on a standard urine drug screen, particularly at lower doses like 0.5 mg. If confirmatory testing is ordered using more sensitive methods like liquid chromatography-mass spectrometry, the drug is much more reliably detected. This matters in two directions: if you are being tested for compliance with a prescription, a negative screen does not necessarily mean you have not been taking your medication. And if someone is concerned about testing positive after a single low dose, the standard screening immunoassay might not even pick it up.
Factors That Make Lorazepam Stay Longer or Shorter
Several variables shift how long a given dose sticks around in your body.
- Age: Older adults clear lorazepam more slowly. While the half-life itself may not change dramatically, total clearance drops by roughly 20% or more. That means the same dose produces somewhat higher and longer-lasting blood levels in someone who is 75 compared with someone who is 25.
- Kidney function: Because lorazepam’s main metabolite is eliminated by the kidneys, you might expect kidney disease to extend the drug’s presence. But the research here is reassuring. A study comparing people with normal kidneys to those with significant renal impairment found no meaningful difference in lorazepam clearance, and the authors concluded no dose adjustment is needed for kidney disease.
- Body composition: Lorazepam distributes into body fat. People with a higher proportion of body fat may see slightly longer persistence, though this effect is modest compared with some other benzodiazepines.
- Liver function: Because glucuronidation is the primary metabolic step, serious liver disease can slow clearance. However, lorazepam is affected less than benzodiazepines that rely on oxidative metabolism.
5PubMed. Effect of renal impairment and hemodialysis on lorazepam kinetics
3PubMed. Lorazepam kinetics in the elderly
Drug Interactions That Slow Clearance
Because lorazepam relies on glucuronidation rather than the cytochrome P450 enzyme system, it has fewer drug interactions than many other benzodiazepines. But “fewer” does not mean “none.” One well-documented interaction is with valproate, a medication commonly used for epilepsy and bipolar disorder. When lorazepam was given alongside divalproex sodium (a form of valproate), lorazepam’s clearance through glucuronidation dropped by about 31%. Trough plasma concentrations of lorazepam, the lowest level between doses, rose by the same amount. Peak plasma concentrations increased by about 8%, and overall drug exposure (measured by area under the curve) went up by 20%.
8PubMed. Effect of valproate on the pharmacokinetics and pharmacodynamics of lorazepamIn practical terms, if you take both lorazepam and valproate, a 0.5 mg dose of lorazepam will linger longer and hit a slightly higher peak than it would alone. Your prescriber should already be accounting for this, but it is worth knowing if you have ever noticed that your Ativan seems more sedating when taken with certain other medications. A follow-up study found that individual genetic variation in the enzymes responsible for glucuronidation could further influence how strongly the valproate interaction affects you, though the pharmacokinetic changes were relatively modest across genotypes.
9PubMed. Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjectsOther medications that inhibit glucuronidation, such as probenecid, can theoretically slow lorazepam clearance as well. And of course, combining lorazepam with alcohol or opioids does not necessarily change how long the drug stays in your system, but it dramatically increases the risk of dangerous sedation, respiratory depression, and overdose, even at low doses like 0.5 mg.
Does the Route of Administration Change How Long It Lasts?
Ativan is most commonly taken as an oral tablet, but lorazepam is also available as a sublingual tablet, an intramuscular injection, and an intravenous formulation. You might assume these different routes would substantially change the drug’s duration, but the pharmacokinetic differences are smaller than you would expect. A study comparing all four routes found that oral, sublingual, and intramuscular lorazepam all reached peak blood levels at similar times (roughly 2.3 to 2.4 hours post-dose) and all achieved close to 100% bioavailability, meaning nearly all of the drug gets into your bloodstream regardless of route.
2PubMed. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepamThe main difference with intravenous administration is speed of onset, not duration. IV lorazepam hits the brain almost immediately, which is why it is the go-to for acute seizures and emergency sedation. But once the drug is in your blood, the half-life and duration are the same regardless of how it got there. So whether you swallowed a 0.5 mg tablet or dissolved it under your tongue, the timeline for how long it stays in your system is essentially identical.
Tolerance With Repeated Use
If you take 0.5 mg of Ativan on a single occasion, the timeline discussed above applies fairly straightforwardly. But if you take it daily for weeks or months, the picture changes in two ways. First, the drug accumulates. With a half-life of around 14 to 16 hours and once- or twice-daily dosing, lorazepam reaches a steady state after about three days of regular use. At steady state, each new dose adds to a baseline level that has not fully cleared, so the effective amount in your system is higher than what a single dose would produce.
Second, tolerance develops. Your brain adapts to the constant presence of the drug, and the same dose produces less effect over time. Research in animal models has shown that tolerance to lorazepam’s sedative effects correlates with measurable changes in how brain receptors respond to the drug.
10Neuropharmacology. Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamateFor the person asking how long 0.5 mg lasts, this means the answer depends on your history with the drug. A first-time user may feel sedated for six or more hours. Someone who has been taking the same dose daily for several weeks may barely notice it. The drug is still in your system for the same length of time either way, but the functional duration, the window where you feel its effects, shrinks with repeated exposure.
What Happens When You Stop
After regular use of even a low dose like 0.5 mg, stopping abruptly can trigger withdrawal symptoms. The most common pattern is a short-lived “rebound” of anxiety and insomnia, appearing within one to four days of the last dose depending on the drug’s half-life.
11PubMed. The benzodiazepine withdrawal syndromeFor lorazepam, with its intermediate half-life, withdrawal symptoms typically begin within one to two days after stopping. At 0.5 mg, the withdrawal is usually milder than at higher doses, but it can still be unpleasant, particularly if the drug was taken daily for more than a few weeks. Symptoms can include heightened anxiety, difficulty sleeping, irritability, and in some cases physical symptoms like headaches and muscle tension. Tapering gradually under medical guidance is the standard approach to minimizing withdrawal, even at low doses.
Overdose Concerns at 0.5 mg
A single 0.5 mg dose of lorazepam is extremely unlikely to cause an overdose in an otherwise healthy adult. This is the lowest commonly prescribed dose, and benzodiazepines taken alone have a relatively wide margin of safety. The real danger comes from combining lorazepam with other central nervous system depressants like alcohol, opioids, or other sedating medications. Even a “tiny” dose of lorazepam taken alongside these substances can tip someone into dangerous respiratory depression.
In cases of benzodiazepine overdose, flumazenil is a reversal agent that can rapidly counteract the sedation. In a controlled trial of self-poisoned patients, flumazenil injection produced a large and statistically significant improvement in consciousness scores within five minutes, and it worked even in patients who had also ingested alcohol alongside benzodiazepines.
12PubMed Central. The effect of flumazenil (Ro 15-1788) in the management of self-induced benzodiazepine poisoning. A double-blind controlled studyFlumazenil is reserved for emergency settings and is not something prescribed for home use. It also carries its own risks, particularly the potential for triggering seizures in people who are dependent on benzodiazepines. But its existence is worth knowing about as a safety net in the rare event of accidental overdose or drug-facilitated poisoning.
A Note on Hemodialysis
For people on dialysis, a common concern is whether the procedure strips medications from the blood. With lorazepam, the answer is mixed. A six-hour hemodialysis session removed only about 8% of intact lorazepam from the bloodstream but cleared around 40% of the inactive glucuronide metabolite.
5PubMed. Effect of renal impairment and hemodialysis on lorazepam kineticsIn practical terms, dialysis does not significantly speed up the removal of active lorazepam from your system. The drug holds on to plasma proteins and distributes into tissues in a way that makes dialysis relatively inefficient at clearing it. If you are on dialysis and take lorazepam, you generally do not need a supplemental dose after a session, nor should you expect dialysis to meaningfully shorten how long the drug’s effects last. The same study also found that lorazepam clearance in people with kidney impairment was not significantly different from people with healthy kidneys, reinforcing that no dose adjustment is typically needed for renal disease alone.